PB2465: ALLOGENEIC HSCT OUTCOMES IN SIX PATIENTS WITH THERAPY RELATED MYELOID NEOPLASMS WITH A HISTORY OF OVARIAN CANCER TREATED WITH CHEMOTERAPY AND PARP INHIBITORS
Alessio Maria Edoardo Maraglino,
Viviana Amato,
Federica Gigli,
Simona Sammassimo,
Rocco Pastano,
Corrado Tarella,
Elisabetta Todisco,
Enrico Derenzini,
Fabio Giglio
Affiliations
Alessio Maria Edoardo Maraglino
1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy
Viviana Amato
1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy
Federica Gigli
1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy
Simona Sammassimo
1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy
Rocco Pastano
1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy
Corrado Tarella
1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy
Elisabetta Todisco
1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy
Enrico Derenzini
1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy
Fabio Giglio
1 European Institute of Oncology, Onco-Hematology Division, Milan, Italy
